NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP
Establishment Labs Holdings Inc. ESTA
9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$211.1M
▲ 27.1% vs FY2024
EPS · FY25
$-1.72
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-133.3%
Net margin · FY25
-24.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 211.1M
Revenue, FY2025 · full 9-year series below
Revenue
Net income
The company lost 24 cents on every revenue dollar this year.
Per share
USD -1.72
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-133.3%
Return on equity, FY2025
ROE
Operating margin-18.5%
Net margin-24.2%
Return on assets-14.5%
Each USD of equity lost 133 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+20.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+9.3%
+20.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years+24.6%
Change, 10 years—
The share count grew 25% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 357.2M
total assets, end of FY2025
Total assetsUSD 357.2M
EquityUSD 23.5M
CashUSD 75.6M
Gross debtUSD 247.5M
Net debtUSD 171.9M
Current ratio3.04×
Net debt stands at 730% of equity.
History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
Operating income $B
−0.0
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.1
−0.0
−0.0
·
·
·
·
Income tax $B
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.72
−3.00
−3.07
−3.08
−1.72
−1.63
−1.86
−1.22
−3.41
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−133.3
−236.7
−1537.7
−353.5
−65.5
−66.5
−69.9
−65.4
·
Shares out B
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
36 of 36
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed